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DDW 2015: Basic and
Translational Activities
and Interestsof theAGACouncilelcome to the May issue of Cellular and MolecularWGastroenterology and Hepatology. It has been an
exciting year for the journal. We unveiled the plan for the
journal at Digestive Disease Week (DDW) 2014 and began
accepting submissions the following month. I am happy to
tell you that the response of the gastrointestinal, liver, and
pancreatic research communities has been strong and sup-
portive. We take this as evidence that there is a pressing
need for a rigorous basic and translational science journal in
our ﬁeld, and reviewing our ﬁrst three issues should
convince anyone that CMGH is rigorous. I also want to
assure all readers and authors that CMGH will be indexed in
PubMed and PubMed Central beginning with the very ﬁrst
issue. Our plans are bold for CMGH. Later this year, we will
be applying for early indexing in PubMed and PubMed
Central. Once CMGH is accepted, the journal will be indexed
from the very ﬁrst issue.
As part of our efforts to support the basic and trans-
lational research communities within the AGA, we have
compiled the following summaries and meeting guides
prepared by the AGA sections listed below. We hope this
will become a regular feature that helps our readers take
advantage of the vast array of offerings at DDW. In addition
to the terriﬁc programing below, be sure to attend the
Section Education and Networking Exchange on Saturday
from 5:30-6:30 p.m. It is an opportunity for attendees to
meet section leaders, see poster presentation, and volunteer
to review abstracts or participate in future sessions at DDW.
Thanks very much to the section chairs and vice chairs
as well as the CMGH managing editor, Lindsey Brounstein,
for doing the major work in preparing this compilation, and
to all of you for your support of the journal. I hope to see
you in Washington, D.C.
JERROLD R. TURNER, MD, PhD
Editor-in-Chief, CMGH
DDW 2015 for the AGA Council
The Grossman Lecture
Gastrointestinal Oncology Section
Growth, Development, and Child Health Section
Immunology, Microbiology, and Inﬂammatory Bowel
Diseases Section
Intestinal Disorders Section
Liver and Biliary Section
Neurogastroenterology and Motility Section
Obesity, Metabolism, and Nutrition Section
Pancreatic Disorders Section
Regulatory Peptides, Cell Signaling, and Molecular
Biology SectionCelluThe Grossman Lecture
Andrew B. Leiter, MD, PhD, and
Charalabos Pothoulakis, MD
Morton Grossman (1919–1981), the father of modern
gastrointestinal endocrine physiology, was truly one of the
giants of the last century in gastrointestinal research.
Dr Grossman’s appointment in 1955 as chief of gastroenter-
ology at the Wadsworth VA Medical Center in Los Angeles
was a major turning point in his career. From 1955 until
1962, he ran the section and trained clinical gastroenterolo-
gists, all the while continuing his research. He was one of the
ﬁrst scientists appointed to the newly created Senior Medical
Investigator program at the VA and was also professor of
medicine and physiology at the UCLA School of Medicine.
In 1973, Dr Grossman learned that the National In-
stitutes of Health intended to fund a center for the study of
peptic ulcer disease. Almost single-handedly he organized
the Wadsworth-UCLA and Dallas GI groups to submit a
proposal, which was funded. Thus, in 1974 Dr Grossman
became the ﬁrst director of the Center for Ulcer Research
and Education (CURE), which served as a prototype for the
Digestive Diseases Research Core Center Program at the
National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK).
During his life, Dr Grossman authored 400 articles. He
trained a generation of fellows and scientists from all parts
of the world. Many of them went on to successful research
careers and to hold positions of distinction as heads of de-
partments of gastroenterology, surgery, and physiology. His
major contributions lay in deﬁning the secretory mecha-
nisms of the stomach and pancreas and the actions of reg-
ulatory gastrointestinal peptides. Dr Grossman set
uncompromising standards for scientiﬁc validity and accu-
racy of reporting. In 1979 he was presented the Frie-
denwald Medal from the American Gastroenterological
Association in recognition of his accomplishments.
His friends and colleagues will most remember his cu-
riosity, his encyclopedic memory, the breadth of his in-
terests and his energy in pursuing them, his intelligence, his
perfectionism, his fairness, his wisdom, his integrity, his
devotion, and his kindness.
The Grossman Distinguished Lectureship was estab-
lished in 1989 to honor the memory and accomplishments
of Dr Grossman. Previous speakers have all been distin-
guished, world-renowned scientists, including eight Nobel
laureates. The 2015 Grossman Lecture will be given by Hans
Clevers, president of the Royal Netherlands Academy of Arts
and Sciences.
Over the last decade, few scientists have had as signiﬁcant
an impact on digestive disease research as Dr Clevers. Over a
decade ago, Dr Clevers identiﬁed a transcription factor TCF1
as a key transcriptional effector protein of the Wnt signaling
pathway. His discovery had amajor impact on understanding
this important pathway in metazoan development. More
importantly his ﬁndings identiﬁed a missing link towardlar and Molecular Gastroenterology and Hepatology 2015;1:249–256
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tations and b-catenin give rise to colorectal cancer.
With the tools he developed for studying Wnt signaling,
Dr Clevers recognized that self-renewing cells at the base of
intestinal crypts showed highly active Wnt signaling. This
critical observation lead to the discovery of a seven trans-
membrane domain receptor, leucine-rich repeat-containing
G-protein coupled receptor 5 (LGR5), as both a Wnt target
gene and a marker of intestinal stem cells (ISC). Although
the existence of a pluripotent intestinal stem had been
proposed for decades, it remained elusive for study because
there were no known markers.
In a series of classic experiments, Clevers and his col-
leagues established that LGR5-expressing cells fulﬁlled the
properties of the long-postulated self-renewing intestinal
stem cell. His discoveries and ongoing work have triggered
an avalanche of information from his laboratory and many
others about the ISC as an adult stem cell, the biology of the
stem cells and their niche, the functional role of LGR5 as an
R-spondin receptor, and the ability to propagate stem cells in
organoid cultures. As a result of his seminal work, the ability
to study stem cells has evolved from experiments that could
never be done, to a wellspring of new knowledge that has
our advanced understanding of the gastrointestinal tract.
Gastrointestinal Oncology Section
William M. Grady, MD, AGAF, and
Rhonda F. Souza, MD, AGAF
The Gastrointestinal Oncology section (GIONC) focuses
on research in biomarkers, colon cancer screening, cancer
chemoprevention, and tumor biology (colorectal cancer,
esophageal cancer, pancreatic cancer, and gastric cancer).
The GIONC section has played a key role in the multisociety
ASCO/AGA/SSO/ASTRO GI Cancers Symposium that is held
annually in January, where section members are key leaders
at this meeting through their roles as members of the pro-
gram committee and steering committee, and as invited
speakers. Additionally, the strength of the GIONC section
comes from its ability to address and highlight broad
themes in oncology that pertain to multiple cancer types,
not only those restricted to a single organ site.
Research Fora
GIONC has developed a program for DDW 2015 that covers
advances in some of the most dynamic areas of gastrointes-
tinal cancer research. Twelve research fora span basic and
translational research on a number of exciting topics.
Saturday, May 16, 2015: “Gastric Neoplasms: Pre-
cursors, Biology, Diagnosis and Therapy,” “Biomarkers for
Detection, Treatment, and Prognosis of GI Cancers,” “Ther-
apy for GI Cancers: Translational and Targeted Approaches,”
“Tumor Biology and Tumor Microenvironment,” “Stem Cell
Biology and Cancer,” and “Inﬂammation, Tumor Microenvi-
ronment, and Pancreatic Carcinogenesis.”
Sunday, May 17, 2015: “Esophageal Neoplasms: Mech-
anisms of Carcinogenesis,” “Cancer Susceptibility and Fa-
milial Cancer Syndromes,” and “Molecular Pathways in
Carcinogenesis, Angiogenesis, and Metastasis.”Monday, May 18, 2015: “Inﬂuences of Nutrition and the
Microbiome on GI Cancers.”
Tuesday, May 19, 2015: “Epigenetics and Gastrointes-
tinal Cancer” and “Cancer Prevention and
Chemoprevention.”
Distinguished Abstract Plenary
Another highlight of DDW 2015 is the GIONC distin-
guished abstract plenary session being held on Monday,
May 18, 2015. This session will feature advances in GI
cancer therapies and biomarkers by showcasing some of the
best posters submitted to our section this year.
Symposia
The GIONC section will also be hosting several symposia
spanning clinical, basic, and translational research. The
global research symposium “RAS Is Back: Novel Approaches
and Insights into RAS and Gastrointestinal Cancer” will be
on Saturday, May 16, 2015. There will be two translational
symposia this year as well. You will not want to miss
“Microbiome, Metabolites, and Cancer” on Saturday, May
16, 2015, or “Role of Inﬂammation in Gastrointestinal
Cancer” on Monday, May 18, 2015. Finally, our clinical
symposium will focus on the crucial debate: “Colonoscopy
vs. Stool Testing for Colon Cancer Screening” and will round
out the week on Tuesday, May 19, 2015.
Growth, Development, and Child
Health Section
Alessio Fasano, MD, and Noah F. Shroyer, PhD
The Growth, Development and Child Health (GDCH)
section is the home for pediatrics and developmental
biology within the AGA. The membership of GDCH has the
most diverse range of digestive health interests within the
AGA, representing the interests of pediatrics within all
digestive organ systems as well as basic science related to
growth, development, and pediatrics.
GDCH received 129 abstracts for DDW 2015, of which 36
(28%) were accepted for oral presentations and 79 (61%)
were accepted as posters. One abstract entitled “Villus
Morphogenesis Re-examined: Unique Cell Division Carve
Out Intestinal Villi” was selected for oral presentation as
part of the AGA Basic Science Plenary. These numbers are
quite similar to the overall number of abstracts submitted
over the past 5 years. For DDW 2015, GDCH is sponsoring
10 oral sessions and four poster sessions.
Research Fora
Seven research fora include oral presentations selected
from the abstracts:
Saturday, May 16, 2015: “The Role of Gut Microbiome
in Pediatric GI Diseases.” At this session, the GDCH section
will also present the section Research Mentor Award to
Richard J. Grand, MD.
Sunday, May 17, 2015: “Pediatric IBD: Clinical and
Translational Studies” and “Molecular Mechanisms and
Signaling of GI Growth and Development.”
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ders,” “Pediatric Functional and Motility Disorders,” and
“Mucosal Growth Factors and Receptors, Intestinal Prolif-
eration, Cell Cycle Regulation, and Apoptosis.”
Tuesday, May 19, 2015: “Challenges and Opportunities
in Pediatric Liver Diseases.”
Symposia
In addition to the abstract-driven research fora, the
GDCH section is sponsoring three clinical and translational
symposia of invited leaders in their ﬁelds.
The translational symposium on Saturday, May 16,
2015 on “Gut Microbiome and Clinical Outcomes in Pedi-
atrics” includes “How Gut Microbiome Is Established: Les-
sons Learned From Premature Infants” (Phillip I. Tar);
“Microbiome and Obesity” (Lee M. Kaplan); “Microbiome
and Food Allergies” (Richard S. Blumberg); and “Micro-
biome and IBD” (Eric Alm).
Another translational symposium on Monday, May 18,
2015, “Celiac Disease—Which Factors Are At Play in Child-
hood That Can Increase the Risk to Develop the Disease in
Adulthood?,” includes “HowHLAHaplotype Can Inﬂuence the
Risk of Developing Celiac Disease” (Edwin Liu); “Timing of
Gluten Introduction and Risk of Celiac Disease” (Carlo Cata-
ssi); “Preventing Celiac Disease” (M. Luisa Mearin); and “The
Role of GutMicrobiome andMetabolome in theOnset of Celiac
Disease in Genetically At-Risk Individuals” (Alessio Fasano).
Lastly, the clinical symposium on Monday, May 18, 2015,
“IBS 21st Century: Time to Switch From Treating Symptoms to
Eliminate the Cause?” includes “IBS 101: What Do WE Know,
WhatWE Don’t Know, HowWE Can Close the Knowledge Gap”
(Carlo Di Lorenzo); “Infective and Allergic Causes of IBS” (Craig
Friesen); “The Role of Food Intolerances in the Pathogenesis of
IBS” (Bruno Champitazi); and “The Intestine Under Stress:
Neuro-Motor Causes of IBS” (Adrian Miranda).
Poster Sessions
Finally, GDCH is sponsoring four poster sessions: “Pedi-
atric IBD,” “Pediatric Functional and Motility Disorders,”
“Clinical Pediatric Gastroenterology,” and “Pediatric Trans-
lational Research.”
Immunology, Microbiology, and
Inﬂammatory Bowel Diseases Section
Edward V. Loftus Jr., MD, AGAF, and
Mark S. Silverberg, MD, PhD
DDWcontinues to be the preeminent scientiﬁcmeeting for
the ﬁeld of inﬂammatory bowel diseases (IBD). The Immu-
nology, Microbiology and Inﬂammatory Bowel Diseases
(IMIBD) section is the largest of the AGA Council sections and
continues to attract the best scientiﬁc work of the year. There
are numerous topic descriptors for abstract submission that
cover the spectrum of basic and translational science related
to IMIBD in addition to clinical science. The section covers
important major scientiﬁc topics such as innate and adaptive
immunity, genetics and the microbiome, animal models of
IBD, mucosal immunology, epithelial cell biology, and stemcells. DDW is an outstanding opportunity for scientists to get
state-of-the-art knowledge in a speciﬁc ﬁeld of interest in
addition to a well-rounded update in the ﬁeld.
For the 2015 meeting there were 1096 abstracts sub-
mitted, with only 9% selected for oral presentation and
about 60% accepted for poster presentation. This was a
particularly competitive year with roughly 30% of
the submitted abstracts rejected. Although it is not neces-
sarily ideal to have such a high rejection rate, this does
result in higher quality presentations at the meeting.
We encourage all members from the scientiﬁc community
interested in the IMIBD topics to attend DDW this year.Research Fora
Some of the most exciting basic and translational high-
lights of the IMIBD section’s 17 research fora are included
here.
These basic research sessions are a must-see at DDW
2015. On Saturday, May 16, 2015, a research forum
addressing progress in developing novel therapeutics using
animal models will take place. As the science evolves from
IBD gene identiﬁcation to gene function and biology, a
Research Forum on Sunday, May 17, 2015, will include
presentations that describe new genetic discoveries as well
as some breakthroughs in understanding the function of
known IBD gene variants. There will also be a mini-state-of-
the-art lecture provided to summarize the current and
future state of affairs in IBD genetics. Other research fora at
DDW will focus on cytokines and receptors, pre and pro-
biotics, and stem cell biology.
Saturday, May 16, 2015: “Using Animal Models to
Develop Novel Therapies,” “IBD: Cytokines, Signaling, and
Receptors,” and “IBD: Innate andAdaptive Immune Function.”
Sunday, May 17, 2015: “The Microbiome in IBD:
Structure and Function” and “Gene Identiﬁcation and Gene
Function in IBD.”
Monday, May 18, 2015: “Stem Cell Biology.”
Tuesday, May 19, 2015: “Prebiotics and Probiotics.”Distinguished Abstract Plenary
The IMIBD distinguished abstract plenary session on
Monday, May 18, 2015, will contain presentations on a large-
scale study examining the composition of the fecal micro-
biome in healthy ﬁrst-degree relatives of Crohn’s disease pa-
tients and the role of RAC proteins in intestinal inﬂammation.
Intestinal Disorders Section
Nicholas O. Davidson, MD, AGAF and
Wayne I. Lencer, MD, AGAF
The Intestinal Disorders (ID) section is the fourth largest
section of AGA Council, receiving 416 abstracts in 2015, of
which 53 (13%)were accepted for oral presentation and 258
(62%) were accepted for poster presentation. These ﬁgures
compare favorably with historical trends for 2012–2014
(oral, range: 13%–17%; poster, range: 57%–63%).
The ID section members’ interests span a range of areas,
embracing disease focused (celiac disease, radiation- and
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cesses (diarrhea and malabsorption, host-microbial in-
teractions, epithelial transport) as well as translational
interests that include epithelial functions and junctions in
wound repair, nutrient and lipid processing, and antigen
sensing/processing in innate immunity. In addition, the ID
section has promoted interest in the use of isolated enter-
oids and organoids for the study of intestinal disease,
reﬂecting the emerging interest in stem cell biology.
Research Fora
For DDW 2015, the ID section is sponsoring eight
research fora, which are aggregated around abstract sub-
missions reﬂecting a general theme. Of these eight research
fora, there is an equal distribution of basic and translational
content. These include:
Saturday, May 16, 2015: “Intestinal Stem Cells, Devel-
opmental Biology, and in Vivo Approaches (Organoids/
Enteroids),” “Microbes, Innate Immunity, Pathogenesis, and
Inﬂammation,” and “Injury Models/Stem Cells.”
Sunday, May 17, 2015: “Intestinal Disorders: Clinical
Mechanisms” and “Inﬂammation, Injury, Repair, and
Fibrosis.”
Monday, May 18, 2015: “Intestinal Physiology, Cell
Biology, and Barrier Function” and “Mechanisms and
Mediators of Diarrhea.”
Tuesday, May 19, 2015: “Updates on the Diagnosis of
Celiac Disease.”
Distinguished Abstract Plenary
In addition to these abstract-driven research fora, there
is a distinguished abstract plenary session (Saturday, May
16, 2015) at which we will present the Research Mentor
Award to Jerrold Turner, MD, PhD. The distinguished ab-
stract plenary session reﬂects a range of high-impact ab-
stracts including both basic and clinical topics.
Symposia
The ID section is also sponsoring a research symposium
(Saturday, May 16, 2015) focused on “Next Generation
Sequencing: Opportunities for Research and Practice.” This
symposium will feature three experts who will discuss
ﬁndings that include “Single-Cell PCR Using Fluidigm
Technology” (Scott Magness); “Functional Heterogeneity of
T-Cell Receptors at the Single Cell Level” (Arnold Han); and
“Next Generation Sequencing in Colorectal Cancer/Polyposis
Syndromes” (Ian Tomlinson). This research symposium will
allow attendees to gain detailed insight into advances in
single-cell transcriptomics and to understand how advances
in sequencing technology are transforming clinical practice
by facilitating subclassiﬁcation of disease phenotypes.
Finally, the ID section is sponsoring two clinical sym-
posia and one translational symposium.
The translational symposium (Saturday, May 16, 2015)
is organized around “Xenobiotics, Microbiota, and Intestinal
Disease” and features three experts who will discuss ﬁnd-
ings that include “Gut Reactions: Understanding Drug
Metabolism by the Human Microbiota” (Emily Balskus);“Xenobiotics and Intestinal Injury (Axel Behrens); and
“Intestinal Efﬂux Transporters and Multidrug Resistance in
Inﬂammation” (Elke Cario). This translational symposium
will allow attendees to gain perspective into how the
microbiota interact with and inﬂuence drug metabolism.
The ﬁrst clinical symposium on Monday, May 18, 2015,
is organized around “Radiation Injury, Intestinal Failure,
and Rehabilitation” and features three experts who will
discuss the current state of the art in this difﬁcult man-
agement problem. Their topics will include “Radiation En-
teropathy: Clinical Perspectives for the Future” (Jerviose
Andreyev); “Intestinal Rehabilitation” (Donald F. Kirby); and
“Managing Sepsis and Infections in Patients with Intestinal
Failure” (Georg Lamprecht). This symposium will provide
attendees with perspectives and insights from European
and U.S. centers of excellence, including very practical de-
tails on preventing and managing important complications
and outlining future directions for the ﬁeld.
The second clinical symposium on Monday, May 18,
2015, is organized around “Celiac Disease: Causes and Di-
lemmas” and features an international group of experts who
will discuss topics including “Why Is Celiac Disease on the
Rise and Can It Be Prevented?” (Anneli Iversson); “Sus-
pected Celiac Disease: How to Secure a Diagnosis”
(Benjamin Lebwohl); “What to Do With Persistent Symp-
toms and/or Partial Recovery?” (Joseph A. Murray); and
“How to Diagnose and Manage Refractory Celiac Disease?”
(Chris J. Mulder). This symposium will provide attendees a
granular understanding of the key challenges in the epide-
miology, diagnosis, and management of celiac disease.Liver and Biliary Section
Jayant A. Talwalkar, MD, MPH, and
Kenneth E. Sherman, MD, PhD
Membership in the Liver and Biliary (LB) section has
seen a slight increase in the past few years. As of May 2014,
the section counts 5038 members, which represents a 3%
increase in membership since 2010. Domestic members
comprise 65% of the section; international members
comprise 18% of the base. More than 14% of the members
are trainees (domestic and international), which represents
one of the highest proportions of trainee members among
all council sections. Nurse practitioners and practice man-
agers comprise just 3% of the membership. Consistent with
other sections, the large majority of Liver and Biliary
members afﬁliate with multiple sections; including Clinical
Practice; Esophageal, Gastric and Duodenal Disorders; and
Intestinal Disorders.Research Fora
The LB section is sponsoring two research fora, which
will have oral abstract presentations centered on general
themes. These include:
Saturday, May 16, 2015: “Metabolic and Genetic Liver
Disease.”
Tuesday, May 19, 2015: “Liver and Biliary Carcinoma:
Management, Etiology, Diagnosis, and Natural History.”
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For DDW 2015, the LB section will offer multiple poster
presentation forums for accepted scientiﬁc abstracts. The
poster sessions will be divided into the following categories:
Saturday, May 16, 2015: “Clinical Biliary Tract Disor-
ders, Stone Diseases, and Stone Pathogenesis.”
Sunday, May 17, 2015: “Clinical Hepatitis.”
Monday, May 18, 2015: “Complications of Cirrhosis and
Portal Hypertension.”
Tuesday, May 19, 2015: “Liver and Biliary Carcinoma,”
“Metabolic and Genetic Liver Disease,” and “Pharmacoe-
conomics and Cost-Effectiveness Analysis of Liver
Disease.”
A jointly sponsored oral presentation session between
the LB section and American Association for the Study of
Liver Disease (AASLD) will also be held on Tuesday, May
19, 2015. Abstract presentations will be centered around
“Noninvasive Markers of Liver Fibrosis.”Symposia
Three clinical symposia are being sponsored indepen-
dently or jointly with other AGA Institute sections at DDW
in 2015.
The clinical symposium on Monday, May 18, 2015, is
focused on “Health Economics of Diagnosis and Treatment
for Chronic Liver Disease.” Expert speakers will speak about
topics including “Pharmacoeconomics of Chronic Viral
Hepatitis “(John Wong); “Economic and Resource Utilization
with MELD for Liver Transplantation” (Shimul Shah); and
“Cost-Effectiveness of Screening and Surveillance for HCC”
(Norah Terrault). This symposium will allow attendees to
hear about the potential economic beneﬁts and impacts for
available and emerging drug therapies.
The Emmett B. Keefe Clinical Symposium on Monday,
May 18, 2015, will be organized around the topic of “Impact
of Long-Term Suppression of Chronic HBV Infection.” Topics
include “The Effect of Long-Term Suppression of HBV on
Immune Function and Cure” (Shyam Kottilil); “Long-Term
Survival and Risk of HCC in HBV Infected Patients Treated
With Long-Term Nucleoside/Nucleotide Therapy” (Stuart
Gordon); and “Cost-Effectiveness of Long-Term Viral Sup-
pression of HBV” (Mark Eckman). This symposium will deal
with an important topic area for the management of patients
with chronic hepatitis B infection.
A joint global clinical symposium sponsored by the
LB and Clinical Practice sections will be held on Tuesday,
May 19, 2015, and will focus on the “Implementation of the
Affordable Care Act and the Practice of Gastroenterology
and Hepatology.” Topics include “Current Concepts in Pro-
vider and System-Based Quality of Care Measurement
“(Spencer Dorn); “Impact of Health Insurance Coverage
from Exchanges on Out-of-Pocket Costs for GI Services” (Joel
Brill); and “Price Transparency, Narrow Networks and Ac-
ademic Health Centers” (Mark McClellan). This novel and
timely symposium will be of great interest to attendees
given the recent changes in health-care reform and what
effects this will have on the practice of gastroenterology and
hepatology.State of the Art
Last but not least, the LB section will once again host the
Charles S. Lieber State-of-the-Art Lecture on Sunday, May
17, 2015. The invited speaker for the Lieber Lecture is Dr
Scott Friedman, who will present on “NASH: The Conver-
gence of Inﬂammation, Fat, and Fibrosis and the Path to
Treatment.”
Neurogastroenterology and
Motility Section
Pankaj J. Pasricha, MD, and Satish S. C. Rao,
MD, PhD, AGAF
There has never been a better time in terms of research
and clinical advances in neurogastroenterology and motility
(NGM). Often considered a “black box” in our specialty, the
last few years have seen a ﬂurry of basic science discoveries,
novel therapeutic targets, reﬁnement of diagnostic tech-
niques, and several promising new drugs in the pipeline. At
this DDW, the NGM section menu reﬂects this spectrum of
innovation and the excitement around it.
Research Fora
There are many exciting fora where cutting-edge science
will be discussed.
Saturday, May 16, 2015: “Microbiota, Metabolites, and
Motility,” “Emerging Paradigms in Pathogenesis of Motility
Disorders,” and “Neuro-Immune Interactions and ENS
Disorders.”
Sunday, May 17, 2015: “Irritable Bowel Syndrome:
From Diagnosis to Treatment,” “Irritable Bowel Syndrome:
Advancing Our Understanding,” and “Fundamental Ad-
vances in Enteric Neurobiology.”
Monday, May 18, 2015: “Generating and Regenerating
the Enteric Nervous System.”
Tuesday, May 19, 2015: “Neurogastroenterology: Cen-
trifugal/Centripetal” and “Sensory Neurobiology.”
Distinguished Abstract Plenary
The culmination of these exciting research fora is the
NGM plenary session on Monday, May 18, 2015, where the
attendees will be able to listen to ﬁrsthand presentations of
the best abstracts highlighting the most signiﬁcant advances
from bench to translational to clinical neuro-
gastroenterology and motility. In addition, they will witness
the presentation of the Research Mentor Award for 2015 to
Michael Camilleri, MD, AGAF.
Symposia
In addition to the research fora at DDW 2015, the NGM
section is sponsoring research, translational, and clinical
symposia that feature expert invited speakers.
The research symposium on Saturday, May 16, 2015,
will be “NGM Cutting-Edge: New Roles for Old Cells.”We are
bringing in experts from outside of gastroenterology to
learn from them how their groundbreaking research can
inform us about possible directions we need to take and
where the next generation of discoveries will come from.
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Sense Bacteria” and Milena Bogunovic will educate us about
“Macrophages and GI Motility.” Finally Kenton Sanders will
discuss the emerging story of “Fibroblasts and Gut Motility.”
This year’s translational symposium will be on Monday,
May 18, 2015, and will focus on “Making Research Work for
Patients—What Is in the Pipeline?” Here we will go to the
next step in translation—learning about new and emerging
diagnostic and therapeutic targets for functional and
motility disorders. We will also assess the current state of
our knowledge about biomarkers for irritable bowel syn-
drome and hear about new directions for microbiota
manipulation for clinical beneﬁt. Our topics and speakers
include “Purinergic Drugs for Management of GI Disorders”
(Fievos L. Christoﬁ); “MicroRNAs, Genomics, and IBS: What
Is the Link and Are We Any Closer to Finding Biomarkers?”
(John W. Wiley); and “Therapeutic Modulation of Gut
Microbiota” (Purna C. Kashyap).
Lastly, our global clinical symposium on Saturday, May
16, 2015, will address “Developing Targeted Drug Therapy
for GI Disease.” An idea or discovery is only important if
patients have access to it—in other words, if it makes it to
the market. In this session, the audience will learn about the
trials and travails of bringing forward new drugs and
developing new targets for symptomatic relief or cure. We
will also listen to the perspective of Big Pharma on GI dis-
orders as a therapeutic area and what it perceives as the
scientiﬁc or market barriers to drug development in
gastroenterology. This will feature the following talks:
“Novel High Throughput Approaches to Development of
Anti-Diarrheals” (Alan S. Verkman); “Facilitating Pathways
to Patients in Functional and Other GI Diseases: What Are
the Roadblocks From a Regulatory Perspective?” (Juli
Tomaino); “What Scares Investors From Investing in GI
Disorders?” (Bruce Robertson); and “How Do We Re-engage
Pharma in GI Drug Development?” (Gareth Hicks).
Obesity, Metabolism, and Nutrition
Section
Lee M. Kaplan, MD, PhD, AGAF, and
Dennis D. Black, MD
In recent years, DDW programming by the Obesity,
Metabolism and Nutrition (OMN) section has emphasized
subject areas that have appealed to a majority of meeting
attendees, especially those afﬁliated not only with the OMN
section but also other sections with which we share com-
mon interests, as reﬂected by our strong participation in
cross-sectional programming. A major emphasis on obesity
and nutritional and metabolic disorders was solidiﬁed by a
section name change in 2013 to “Obesity, Metabolism and
Nutrition,” reﬂecting a research and clinical focus on this
spectrum of major health problems. New programming has
included fora and symposia highlighting related topics,
including bariatric surgery and its impact on nutritional
status, GI neuroendocrinology and metabolism, new and
innovative endoscopic and other treatments of obesity and
diabetes, fatty liver disease, GI regulation of energy balance,
weight and metabolic function, microbiota and metabolicregulation, and nutrition and metabolism across the life
cycle. Nutritional support in all of its forms used in the
management of a variety of diseases—including obesity,
intestinal failure, and inﬂammatory bowel disease as well as
nutrient absorption and metabolism—have also continued
to be the focus of OMN programming. The OMN section also
has endeavored to strike a balance between basic research
to shed light on disease mechanisms, including preclinical
studies to develop new therapies, and clinical and trans-
lational research to better describe disease phenotypes and
test new therapeutic approaches.
The OMN section received 139 abstracts in 2014 and
137 in 2015, higher numbers than the previous years. In
2015, 25 (23%) were accepted for oral presentations, and
82 (77%) were accepted for poster presentations.
Research Fora
For DDW 2015, the OMN section is sponsoring four
research fora, each with a focused theme and encompassing
basic and translational research. These include:
Saturday, May 16, 2015: “Obesity: Basic and Clinical
Studies” and “Neuroendocrine Regulation of Food Intake
and Energy Expenditure.”
Sunday, May 17, 2015: “Gut Microbiota and Metabolic
Regulation.”
Tuesday, May 19, 2015: “Vitamin and Nutrient
Absorption and Metabolism.”
Symposia
In addition to these research fora, the OMN section will
be sponsoring four themed symposia.
Saturday, May 16, 2015: “Nutrition, Epigenetics, and
Metabolic Imprinting.” This research symposium will
feature three experts discussing the role of early environ-
mental and nutritional exposures in epigenetic alteration
and metabolic imprinting, which have important implica-
tions for obesity and metabolic risk later in life. They
include “Early Environmental Inﬂuences on Intestinal
Developmental Epigenetics” (Lanlan Shen); “Inﬂuence of
Early Life Nutrition on Future Energy Balance” (Karen
Peterson); and “Environmental Exposure and Epigenetics of
Metabolic Syndrome” (Ann Scheimann).
“Intestinal and Hepatic Lipid Droplets in Health and
Disease.” This research symposium will bring together four
experts on the biology of enterocyte and hepatocyte cyto-
plasmic lipid droplets and their roles in lipid storage and
trafﬁcking and their potential as therapeutic targets for
obesity and nonalcoholic fatty liver disease (NAFLD). These
include “Mechanisms of Lipid Synthesis and Storage in Lipid
Droplets” (Robert Farese); “Cytoplasmic Lipid Droplet Syn-
thesis and Catabolism in Enterocytes” (Kimberly Buhman);
“Control of Lipolysis in Lipid Droplets by Perilipin (Dawn
Brasaemle); and “The Lipid Droplet as a Therapeutic Target
in NAFLD” (Jurgen Borlak).
“Eating Fat: The Good, the Bad and the Ugly.” This global
translational symposium will address the impact of reduc-
tion in fat content of the American diet over the past 40
years on the emergence of obesity and metabolic syndrome
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tinal inﬂammation, and malignancy. Topics include “Why
Low-Fat, Low-Calorie Diets Don’t Work” (David Ludwig);
“Nutrigenomics, Dietary Fatty Acids and Metabolic Syn-
drome” (Helen Roche); “Dietary Fat, the Gut Microbiome, and
Metabolic Risk” (Eugene B. Chang); and “Impact of Dietary
Fat on Intestinal Inﬂammation and Malignancy (R. Balfour
Sartor). During this symposium the OMN Section Research
Mentor Award will be presented to Samuel Kline, MD.
Monday, May 18, 2015: “Molecular Mechanisms of In-
testinal Lipid Absorption: Targets for Obesity Therapy.” This
translational symposium will update attendees on the latest
discoveries deﬁning mechanisms of intestinal lipid absorp-
tion at the molecular level and potential targets for the
treatment of obesity. Topics include “Microsomal Triglyc-
eride Transfer Protein” (M. Mahmood Hussain); “The Pre-
Chylomicron Transport Vesicle” (Charles M. Mansbach, II);
“DGAT and MGAT in ER Triacylglycerol Synthesis” (Scot
Stone); and “CNS Regulation of Intestinal Lipoprotein Pro-
duction” (Khosrow Adeli).Poster Sessions
Poster sessions scheduled for Saturday, May 16, 2015,
through Tuesday, May 19, 2015, will cover an array of
topics, including “GI Regulation of Metabolic Function,”
“Nutrient Absorption and Intestinal Epithelial Function,”
“Prebiotics and Probiotics,” “Vitamins and Micronutrients:
Basic and Clinical,” “Intestinal Failure and Therapy: Basic
and Clinical,” “Gut Microbiota and Metabolic Regulation,”
“Obesity: Basic and Mechanistic Studies,” “Innovative
Treatments for Obesity,” “Obesity: Clinical and Epidemio-
logic Studies,” “Nutritional Support: Enteral and Parenteral,”
and “Surgical and Endoscopic Treatment of Obesity and
Metabolic Disorders.”
Pancreatic Disorders Section
Matthew J. DiMagno, MD, and Santhi S. Vege,
MD, AGAF, FACG, FACP
The Pancreatic Disorders (PAN) Section of the AGA
Institute Council has an exciting clinical, translational, and
basic science program at DDW 2015. Herein we highlight
basic and translational sessions that you will not want to
miss.Research Fora
Saturday, May 16, 2015: “Pancreatic Cystic Neoplasms
and Cancer” examines the diagnostic and prognostic value of
biomarkers for pancreatic cancer and the emerging epide-
miologic and cost data that impact evaluation and moni-
toring strategies for branch duct intraductal papillary
mucinous neoplasms (IPMNs).
Sunday, May 17, 2015: “Pathobiology of the Pancreas”
addresses the intrapancreatic effects of transforming
growth factor b (TGF-b) on pain behavior; the relationships
among dietary fat, body mass index, and severity of acute
pancreatitis; how a defective unfolded protein response
promotes pancreatic cell injury and gland ﬁbrosis; and howpancreatic tumorigenic behavior is fostered by pancreatic
stellate cell exosomes and by tumor BclxL expression.
Symposia
The PAN section is cosponsoring an exciting research
symposium on Monday, May 18, 2015: “Irritant Sensing in
the Gut: New Pathways to Visceral Pain of Digestive
Diseases.”
The clinical symposium on Saturday, May 16, 2015, will
be on “Clinical Targeting of Stellate Cells and Autophagy in
Pancreatic Cancer: Hope for Patients or Potential Disaster?”
Experts in the ﬁeld will focus on evolving clinical treatment
targets for pancreatic cancer, and the paradoxical pro- and
antineoplastic effects of stellate cells and inhibition of
autophagy on pancreatic cancer.
On Saturday, May 16, 2015, PAN will host a global trans-
lational symposium on “Epigenetics: A New Paradigm for
Complex GI Diseases,” which will introduce an exciting
new paradigm for understanding, diagnosing, and treating
complexGIdiseases, includingpancreatitis,ﬁbrosis, and cancer.
Sunday, May 17, 2015, will bring “Are Biomarkers
Practical for Early Detection and Prognosis of Pancreatic
Cancer?” Here, experts will review deﬁnitions for high-risk
groups and early detection methods; screening and ge-
netic testing; molecular biomarkers for early detection of
pancreatic cancer; and current and future options for pre-
venting pancreas cells with common Kras mutations from
progressing to cancer.
Other Events
Beyond the research fora and symposia, there are plenty
of other exciting events happening in the PAN section at
DDW 2015.
Highlights of the poster sessions include “Pancreatic Ge-
netics, Epigenetics and Pathobiology of the Pancreas” and
“Pancreatic Cancer Risk Factors, Biomarkers and Diagnosis”
on Saturday, May 16, 2015, and “Pancreatitis: Inﬂammation,
Fibrogenesis, and Immunology” on Tuesday, May 19, 2015.
On Sunday, May 17, 2015, do not miss the AGA Focused
Research Roundtable on “Insights Into Acinar Cells and
Pancreatitis” featuring Dr Fred Gorelick who will discuss
relevant basic research abstracts submitted to DDW 2015.
At noon, join Dr Steven Pandol for a DDW Meet the Inves-
tigator Luncheon entitled “Emerging Bench to Bedside
Treatments of Acute Pancreatitis.” In the afternoon, attend
the AGA/ASGE Presidential Plenary.
Monday, May 18, 2015, brings more PAN events. At
noon, join Dr Roger Liddle for a DDW Meet the Investigator
Luncheon entitled “Neurogenic Inﬂammation and Pain in
the Pancreas.” Also attend the distinguished abstract ple-
nary session, which features top abstracts and presenters
reporting key transcription factors responsible for pancre-
atic regeneration after injury, how pharmacologic inhibition
of TGF-b reverses pancreatic ﬁbrosis, novel imaging tech-
niques to understand pancreatic microenvironment in
pancreatic intraepithelial neoplasia (PanIN) development
and gut permeability in pancreatitis, and the predictive
value of K-Ras biomarkers for pancreatic cancer.
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Update on Pancreatic Cancer Screening,” which will review
the diagnostic and/or prognostic value of biomarkers for
pancreatic cancer and will highlight other methods for risk-
stratifying pancreatic cancer and cancer precursor lesions.
Regulatory Peptides, Cell Signaling, and
Molecular Biology Section
Andrew B. Leiter, MD, PhD, and
Charalabos Pothoulakis, MD
The AGA Council section “Regulatory Peptides, Cell
Signaling, and Molecular Biology” (RPCMB) has broad in-
terests in the basic mechanisms underlying digestive dis-
eases and gastrointestinal physiology. From its origins in the
study of gastrointestinal hormones, the section’s member-
ship has interests representing many areas of cutting-edge
science including growth factors and stem cells, cellular
differentiation in the GI track, epigenetics, mechanisms of
receptor function, luminal chemosensing, intestinal inﬂam-
mation, and mucosal injury and healing. Given the mem-
bership’s strong interest in basic mechanisms, RPCMB has
invited outside speakers who are leading scientists in their
ﬁelds. Our section believes that it is an excellent opportunity
to include the latest highly innovative scientiﬁc advances in
the program at DDW before their incorporation into main-
line digestive diseases research. This is clearly reﬂected in
the quality of the speakers and cutting-edge research
themes sponsored by RPCMB during DDW every year.
RPCMB will sponsor four invited speakers, three
research fora, and four poster sessions as well as cospon-
soring the Morton I. Grossman Lecture. We have an exciting
lineup for DDW 2015.
State of the Art
Leonard Shultz from The Jackson Laboratory will be our
State of the Art speaker (Saturday, May 16, 2015). Dr Shultz
has pioneered genetically engineered mice that carry hu-
manized immune systems. Generation of mice customized to
a speciﬁc patient’s immune system may provide avatars for
studying immune dysregulation occurring in cancer and
autoimmune diseases. This approach may eventually lead to
new therapies that are customized to individual patients.Research Fora
Saturday, May 16, 2015: “Receptors and Signaling
Pathways—Mechanisms Underlying GI Function.”
Monday, May 18, 2015: “Molecular Mechanisms
Underlying Mucosal Injury and Repair” and “Cell Differen-
tiation and Specialization in the GI Tract.”Distinguished Abstract Plenary
We will hold our section’s distinguished abstract plenary
session on Saturday, May 16, 2015. Six outstanding ab-
stracts will focus on themes of cell signaling and growth
factors. Our brief business meeting afterward is an excellent
opportunity for younger investigators to get involved with
planning DDW in the future. We welcome everyone with an
interest in helping plan our section’s program in the future.Symposia
The RPCMB section is sponsoring three additional
invited-speaker research symposia entitled “Plasticity of
Differentiated GI Cells in Choice of Cell Fate and Develop-
ment of Tumors” (Saturday, May 16, 2015); “The Epige-
netic Landscape Controlling Gene Expression in the
Gastrointestinal Tract” (Sunday, May 17, 2015); and “Irri-
tant Sensing in the Gut: New Pathways to Visceral Pain of
Digestive Diseases” (Monday, May 16, 2015).The Grossman Lecture
Our section is pleased to cosponsor the Morton I.
Grossman Lecture (Sunday, May 17, 2015). This year’s
speaker will be Hans Clevers. Dr Clevers’s pioneering
studies have elucidated the mechanisms of Wnt signaling in
the GI tract and have led to identiﬁcation and character-
ization of intestinal stem cells. The title of his presentation
will be “Lgr5 Stem Cells in Gastroenterology.”
We look forward to seeing you at DDW.© 2015 The Author. Published by Elsevier Inc. on behalf of the AGA
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